Literature DB >> 17192540

Human Trypanosoma evansi infection linked to a lack of apolipoprotein L-I.

Benoit Vanhollebeke1, Philippe Truc, Philippe Poelvoorde, Annette Pays, Prashant P Joshi, Ravindra Katti, Jean G Jannin, Etienne Pays.   

Abstract

Humans have innate immunity against Trypanosoma brucei brucei that is known to involve apolipoprotein L-I (APOL1). Recently, a case of T. evansi infection in a human was identified in India. We investigated whether the APOL1 pathway was involved in this occurrence. The serum of the infected patient was found to have no trypanolytic activity, and the finding was linked to the lack of APOL1, which was due to frameshift mutations in both APOL1 alleles. Trypanolytic activity was restored by the addition of recombinant APOL1. The lack of APOL1 explained the patient's infection with T. evansi. Copyright 2006 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17192540     DOI: 10.1056/NEJMoa063265

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  68 in total

1.  Prophylactic antiparasitic transgenesis for human parasitic disease?

Authors:  Julius Lukeš; Jayne Raper
Journal:  Mol Ther       Date:  2010-10       Impact factor: 11.454

Review 2.  The protein cargo of HDL: implications for vascular wall biology and therapeutics.

Authors:  Jay W Heinecke
Journal:  J Clin Lipidol       Date:  2010 Sep-Oct       Impact factor: 4.766

3.  Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Authors:  Elaine Ku; Michael S Lipkowitz; Lawrence J Appel; Afshin Parsa; Jennifer Gassman; David V Glidden; Miroslaw Smogorzewski; Chi-Yuan Hsu
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

4.  Biology of Trypanosoma (Trypanozoon) evansi in experimental heterologous mammalian hosts.

Authors:  K K Misra; S Roy; A Choudhury
Journal:  J Parasit Dis       Date:  2015-01-20

5.  The apolipoprotein L family of programmed cell death and immunity genes rapidly evolved in primates at discrete sites of host-pathogen interactions.

Authors:  Eric E Smith; Harmit S Malik
Journal:  Genome Res       Date:  2009-03-19       Impact factor: 9.043

6.  C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.

Authors:  Laurence Lecordier; Benoit Vanhollebeke; Philippe Poelvoorde; Patricia Tebabi; Françoise Paturiaux-Hanocq; Fabienne Andris; Laurence Lins; Etienne Pays
Journal:  PLoS Pathog       Date:  2009-12-04       Impact factor: 6.823

7.  Population genomics of parallel adaptation in threespine stickleback using sequenced RAD tags.

Authors:  Paul A Hohenlohe; Susan Bassham; Paul D Etter; Nicholas Stiffler; Eric A Johnson; William A Cresko
Journal:  PLoS Genet       Date:  2010-02-26       Impact factor: 5.917

8.  Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi.

Authors:  Nathan Habila; Abel S Agbaji; Zakari Ladan; Isaac A Bello; Emmanuel Haruna; Monday A Dakare; Taofiq O Atolagbe
Journal:  J Parasitol Res       Date:  2010-03-28

9.  Towards a new reference test for surra in camels.

Authors:  Thao Tran; Filip Claes; Didier Verloo; Henri De Greve; Philippe Büscher
Journal:  Clin Vaccine Immunol       Date:  2009-04-29

Review 10.  The natural progression of Gambiense sleeping sickness: what is the evidence?

Authors:  Francesco Checchi; João A N Filipe; Michael P Barrett; Daniel Chandramohan
Journal:  PLoS Negl Trop Dis       Date:  2008-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.